When you take on a big pharmaceutical company, it’s not enough to just have a lawyer! Our attorney, Dr. Tara Tabatabaie, holds a PhD in Chemistry and has spent years in biomedical research. She truly understands how the drugs you have been prescribed can cause serious injury or even death. Such focused understanding and talent is what distinguishes A. Daniel Woska & Associates from most other law firms. The big pharmaceutical companies do not want to see Tara on your side of a lawsuit because she knows what’s really happening with their drugs. If you or someone you love has suffered harm from a defective pharmaceutical, you may be eligible for a potential financial settlement. We want to hear from you today. Dr. Tabatabaie is an experienced pharmaceutical lawyer who can evaluate your case, answer your questions, help you understand your legal rights and pursue those rights on your behalf.
If you have been injured by defective drugs or medical devices, A. Daniel Woska & Associates, P.C. has a team of experienced pharmaceutical and medical device lawyers that can handle your case and help you navigate the complicated world of pharmaceutical and defective medical device litigation. We assist our clients in supporting their rights as they struggle against the rich and powerful. Those rights include the constitutional provision of a trial by jury as a way of balancing justice between the weak and the powerful and the rich and the economically underprivileged. We are here to make sure justice prevails.
Pharmaceuticals
-
The FDA says that doctors should no longer prescribe simvastatin, a cholesterol-lowering statin drug, at the highest approved dosage of 80 mg, as it has been linked to increased risk of muscle damage at this dose. It’s well known that muscle pain and weakness are a common side effect of all statin drugs, but there … -
The Merck drug known as Propecia (also known as finasteride) for hair loss, when it appears to have the side effect of causing erectile dysfunction and loss of libido in men. Perhaps more importantly, this 5-alpha-reductase inhibitors are a drug which can also cause or increase the risk of severe prostate cancer. Using the Gleason … -
What is Avandia? Rosiglitazone, marketed as Avandia, was approved by the Food and Drug Agency (FDA) for treatment of type II diabetes on May 25, 1999. Diabetic patients are at increased risk of heart attack and stroke. Maintaining lower blood sugar levels is believed to prevent diabetes long-term complications including cardiovascular disease and heart attacks. … -
Novartis, the manufacturer of Zelnorm, has notified the FDA that they will no longer provide Zelnorm (tegaserod maleate) under a treatment investigational new drug application (T-IND) protocol to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in women younger than 55. Novartis has agreed to continue to supply Zelnorm for use … -
Meridia (sibutramine), which was manufactured by Abbott Laboratories, was first approved by the FDA in 1997 as a prescription-only weight loss supplement for obese patients with other risk factors such as diabetes, high cholesterol and controlled blood pressure. In October 2010, the FDA announced that the drug would be recalled due to an increased risk … -
YAZ and Yasmin are two nearly identical birth control pills. It has now been shown that women of all ages who use these drugs are at risk for heart attacks, strokes, and deep vein thrombosis. YAZ and Yasmin are manufactured by the German pharmaceutical giant, Bayer. YAZ and Yasmin are the only two birth control … -
Accutane has been manufactured and marketed by the Swiss drug company, Hoffman-La Roche as a long-term treatment for severe acne that does not respond to other forms of treatment. About 13 million people have taken Accutane since it was introduced in 1982. Accutane has been associated with several serious side effects including birth defects, depression … -
Manufacturer Pulls Darvon, Darvocet from the Market; FDA Wants Makers of the Generic Form to Do the Same Painkillers Found to Be Toxic to Heart and Produce Deadly Heart Rhythm Irregularities The U.S. Food and Drug Administration announced on November 2010 that it is pulling off the prescription painkillers Darvon and Darvocet, which combines Darvon … -
Raptiva (efalizumab) is a prescription drug designed to treat psoriasis. It was developed by the pharmaceutical company Genentech. Raptiva, which is administered through weekly injections, alleviates the symptoms of psoriasis by suppressing the formation of T cells, a type of white blood cell which cause inflammation of the skin associated with psoriasis. It is a … -
Reglan (metoclopramide) is a prescription drug used to treat gastrointestinal problems in children and adults. Post-operative patients and those undergoing cancer treatments may be given Reglan to reduce nausea and vomiting. Children and adults with gastroesophageal reflux (GER) and gastroesophageal reflux disease (GERD), diabetic gastroparesis, and other related conditions are often prescribed Reglan. Infants are … -
Aranesp, also known as darbepoetin alfa, is manufactured by Amgen Inc. In 2001, the FDA approved Aranesp to treat anemia in cancer patients receiving chemotherapy treatment and kidney failure patients on dialysis. Aranesp is extensively used in the United States; however, Aranesp is linked to severe and sometimes fatal side effects including blood clots, heart …
Medical Devices
-
The “memory recoil ring” that opens the Bard® Composix® Kugel® Mesh Patch can break under the stress of placement of the large sized products in the intra-abdominal (inside the belly area) space. This can lead to bowel perforations (rupture) and/or chronic (recurring) intestinal fistulae (abnormal connections or passageways between the intestines and other organs). On … -
Hip replacement surgery is considered one of the most successful orthopedic surgeries one can undergo, as judged by patient satisfaction. And thanks to new techniques, many hip replacements are minimally invasive, resulting in shorter hospital stays, faster rehabilitation, and improved results. An artificial hip recipient can expect his or her implant to last, on average, …
* Please note that settlement and recovery results vary per client. Settlement amounts vary with specific facts of each case. Recovery amounts in past cases are no guarantee of future amounts.